Collaboration to develop a cancer therapy to be used with immune checkpoint inhibitors

By |2018-02-28T13:08:27+00:0028 Feb 2018|Drug treatments|

Bristol-Myers Squibb and Nektar Therapeutics are working together to develop a cancer therapy [...]